Emergent BioSolutions Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Emergent BioSolutions Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- EBS
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001367644
Board of directors
-
Donald W. DeGolyer · DirectorSince 2023
-
Jerome M. Hauer · DirectorSince 2023
-
John D. Fowler Jr. · DirectorSince 2026
-
Joseph C. Papa · Director · President and CEOSince 2024
-
Kathryn C. Zoon · DirectorSince 2023
-
Keith Katkin · DirectorSince 2023
-
Louis W. Sullivan · DirectorSince 2023
-
Marvin L. White · DirectorSince 2023
-
Neal Franklin Fowler · DirectorSince 2023
-
Robert Kramer · Director · President and CEOSince 2023
-
Ronald Richard · DirectorSince 2023
-
Sujata Tyagi Dayal · DirectorSince 2023
-
Zsolt Harsanyi · Director · ChairmanSince 2023
Chief executives
Robert Kramer
· President and CEO
Dates unknown
Joseph C. Papa
· President and CEO
Since February 2024
Board connections
5 of this board's directors also sit on 6 other boards.
- via Marvin L. White and Zsolt Harsanyi
- via Joseph C. Papa
- via Keith Katkin
- via Joseph C. Papa
- via Keith Katkin
- via Louis W. Sullivan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,419,523
- 14 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Williams Paul Anthony Officer (SVP, Products Business) | Open-market sale | −3,000 | $8.40 | $25,200 |
| Jun 8, 2026 | Williams Paul Anthony Officer (SVP, Products Business) | Shares withheld for tax | −694 | $8.00 | $5,552 |
| Jun 8, 2026 | Richard S. Lindahl Officer (EVP, Chief Financial Officer) | Shares withheld for tax | −3,964 | $8.00 | $31,712 |
| Jun 8, 2026 | Glessner Coleen Officer (EVP, Quality & Ethics, and CPL) | Shares withheld for tax | −2,018 | $8.00 | $16,144 |
| Jun 8, 2026 | Hartzel William Officer (SVP, Bioservices) | Shares withheld for tax | −1,741 | $8.00 | $13,928 |
| May 1, 2026 | Sujata Tyagi Dayal Director | Open-market sale | −12,781 | $8.36 | $106,849 |
| May 1, 2026 | Donald W. DeGolyer Director | Open-market sale | −14,527 | $8.36 | $121,446 |
| May 1, 2026 | Kathryn C. Zoon Director | Open-market sale | −16,145 | $8.36 | $134,972 |
| May 1, 2026 | Sujata Tyagi Dayal Director | Open-market sale | −980 | $8.94 | $8,761 |
| May 1, 2026 | Donald W. DeGolyer Director | Open-market sale | −954 | $8.96 | $8,548 |
| May 1, 2026 | Kathryn C. Zoon Director | Open-market sale | −1,057 | $8.97 | $9,481 |
| Apr 30, 2026 | Sujata Tyagi Dayal Director | Grant or award | +25,344 | — | — |
| Apr 30, 2026 | Donald W. DeGolyer Director | Grant or award | +25,344 | — | — |
| Apr 30, 2026 | Keith Katkin Director | Grant or award | +25,344 | — | — |
| Apr 30, 2026 | Marvin L. White Director | Grant or award | +25,344 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.